China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 4.940
-0.010 (-0.20%)
Sep 10, 2025, 1:44 PM HKT
HKG:3320 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 260,942 | 257,673 | 244,704 | 218,183 | 192,920 | 168,764 | Upgrade | |
Revenue Growth (YoY) | 4.18% | 5.30% | 12.16% | 13.10% | 14.31% | -7.66% | Upgrade |
Cost of Revenue | 219,677 | 216,984 | 206,366 | 184,564 | 164,096 | 141,571 | Upgrade |
Gross Profit | 41,265 | 40,689 | 38,337 | 33,619 | 28,823 | 27,193 | Upgrade |
Selling, General & Admin | 27,329 | 26,556 | 25,262 | 21,999 | 19,383 | 18,198 | Upgrade |
Other Operating Expenses | 2,174 | 2,148 | 2,044 | 1,878 | 1,422 | 1,134 | Upgrade |
Operating Expenses | 29,504 | 28,704 | 27,306 | 23,878 | 20,805 | 19,332 | Upgrade |
Operating Income | 11,761 | 11,985 | 11,031 | 9,741 | 8,019 | 7,861 | Upgrade |
Interest Expense | -2,091 | -2,262 | -2,363 | -2,428 | -2,209 | -2,639 | Upgrade |
Interest & Investment Income | 580.22 | 681.1 | 587.69 | 721.18 | 595.97 | 572.74 | Upgrade |
Earnings From Equity Investments | 282.48 | 368.01 | 417.11 | 332.34 | 255.48 | 174.18 | Upgrade |
Other Non Operating Income (Expenses) | 995.62 | 1,007 | 1,057 | 181.76 | 287.98 | 470.95 | Upgrade |
EBT Excluding Unusual Items | 11,529 | 11,779 | 10,731 | 8,549 | 6,950 | 6,439 | Upgrade |
Merger & Restructuring Charges | -1.18 | -1.18 | - | - | -7.02 | -1.13 | Upgrade |
Impairment of Goodwill | -92.23 | -92.23 | -82.81 | -85.14 | -100.82 | -495.24 | Upgrade |
Gain (Loss) on Sale of Investments | -1,075 | -720.41 | -220.69 | -166.16 | 101.66 | 90.83 | Upgrade |
Gain (Loss) on Sale of Assets | 76.74 | 70.12 | 63.85 | 334.84 | 7.83 | -15.03 | Upgrade |
Asset Writedown | -211.05 | -178.87 | -611.12 | -271.11 | -115.43 | -76.02 | Upgrade |
Other Unusual Items | 73.27 | 73.27 | - | - | 14.22 | 15.23 | Upgrade |
Pretax Income | 10,300 | 10,930 | 9,880 | 8,361 | 6,850 | 5,958 | Upgrade |
Income Tax Expense | 2,383 | 2,527 | 2,105 | 1,703 | 1,435 | 1,475 | Upgrade |
Earnings From Continuing Operations | 7,916 | 8,403 | 7,775 | 6,658 | 5,415 | 4,483 | Upgrade |
Minority Interest in Earnings | -5,093 | -5,052 | -3,921 | -3,158 | -2,345 | -1,706 | Upgrade |
Net Income | 2,823 | 3,351 | 3,854 | 3,500 | 3,070 | 2,776 | Upgrade |
Preferred Dividends & Other Adjustments | 23.54 | 19.59 | - | - | - | - | Upgrade |
Net Income to Common | 2,800 | 3,331 | 3,854 | 3,500 | 3,070 | 2,776 | Upgrade |
Net Income Growth | -25.26% | -13.06% | 10.11% | 14.00% | 10.59% | -5.50% | Upgrade |
Shares Outstanding (Basic) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | Upgrade |
Shares Outstanding (Diluted) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | Upgrade |
Shares Change (YoY) | - | - | - | - | -0.01% | -0.02% | Upgrade |
EPS (Basic) | 0.45 | 0.53 | 0.61 | 0.56 | 0.49 | 0.44 | Upgrade |
EPS (Diluted) | 0.45 | 0.53 | 0.61 | 0.56 | 0.49 | 0.44 | Upgrade |
EPS Growth | -24.91% | -13.57% | 10.11% | 14.00% | 10.60% | -5.48% | Upgrade |
Free Cash Flow | - | 14,891 | 13,027 | 8,542 | 8,495 | 5,504 | Upgrade |
Free Cash Flow Per Share | - | 2.37 | 2.07 | 1.36 | 1.35 | 0.88 | Upgrade |
Dividend Per Share | 0.124 | 0.135 | 0.154 | 0.142 | 0.122 | 0.101 | Upgrade |
Dividend Growth | -47.68% | -12.34% | 8.81% | 15.82% | 20.94% | 2.76% | Upgrade |
Gross Margin | 15.81% | 15.79% | 15.67% | 15.41% | 14.94% | 16.11% | Upgrade |
Operating Margin | 4.51% | 4.65% | 4.51% | 4.46% | 4.16% | 4.66% | Upgrade |
Profit Margin | 1.07% | 1.29% | 1.57% | 1.60% | 1.59% | 1.65% | Upgrade |
Free Cash Flow Margin | - | 5.78% | 5.32% | 3.91% | 4.40% | 3.26% | Upgrade |
EBITDA | 14,450 | 14,637 | 13,570 | 11,688 | 9,732 | 9,329 | Upgrade |
EBITDA Margin | 5.54% | 5.68% | 5.54% | 5.36% | 5.04% | 5.53% | Upgrade |
D&A For EBITDA | 2,689 | 2,652 | 2,539 | 1,947 | 1,713 | 1,468 | Upgrade |
EBIT | 11,761 | 11,985 | 11,031 | 9,741 | 8,019 | 7,861 | Upgrade |
EBIT Margin | 4.51% | 4.65% | 4.51% | 4.46% | 4.16% | 4.66% | Upgrade |
Effective Tax Rate | 23.14% | 23.12% | 21.31% | 20.37% | 20.94% | 24.76% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.